클로미펜에 부적절한 반응을 보이는 다낭성 난소 증후군 환자에서 Aromatase Inhibitor의 유용성

Effect of Aromatase Inhibitor (AI) in Polycystic Ovary Syndrome Patients with an Inadequate Response to Clomiphene Citrate

  • 김혜옥 (성균관대학교 의과대학 삼성제일병원 산부인과 불임 및 생식내분비) ;
  • 양광문 (성균관대학교 의과대학 삼성제일병원 산부인과 불임 및 생식내분비) ;
  • 허걸 (성균관대학교 의과대학 삼성제일병원 산부인과 불임 및 생식내분비) ;
  • 박찬우 (성균관대학교 의과대학 삼성제일병원 산부인과 불임 및 생식내분비) ;
  • 차선화 (성균관대학교 의과대학 삼성제일병원 산부인과 불임 및 생식내분비) ;
  • 김해숙 (성균관대학교 의과대학 삼성제일병원 산부인과 불임 및 생식내분비) ;
  • 김진영 (성균관대학교 의과대학 삼성제일병원 산부인과 불임 및 생식내분비) ;
  • 송인옥 (성균관대학교 의과대학 삼성제일병원 산부인과 불임 및 생식내분비) ;
  • 궁미경 (성균관대학교 의과대학 삼성제일병원 산부인과 불임 및 생식내분비)
  • Kim, Hye Ok (Department of Obstetrics and Gynecology, Samsung Cheil Hospital & Women's Healthcare Center, Sungkyunkwan University School of Medicine) ;
  • Yang, Kwang Moon (Department of Obstetrics and Gynecology, Samsung Cheil Hospital & Women's Healthcare Center, Sungkyunkwan University School of Medicine) ;
  • Hur, Kuol (Department of Obstetrics and Gynecology, Samsung Cheil Hospital & Women's Healthcare Center, Sungkyunkwan University School of Medicine) ;
  • Park, Chan Woo (Department of Obstetrics and Gynecology, Samsung Cheil Hospital & Women's Healthcare Center, Sungkyunkwan University School of Medicine) ;
  • Cha, Sun Hwa (Department of Obstetrics and Gynecology, Samsung Cheil Hospital & Women's Healthcare Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Hae Suk (Department of Obstetrics and Gynecology, Samsung Cheil Hospital & Women's Healthcare Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Jin Yeong (Department of Obstetrics and Gynecology, Samsung Cheil Hospital & Women's Healthcare Center, Sungkyunkwan University School of Medicine) ;
  • Song, In Ok (Department of Obstetrics and Gynecology, Samsung Cheil Hospital & Women's Healthcare Center, Sungkyunkwan University School of Medicine) ;
  • Koong, Mi Kyung (Department of Obstetrics and Gynecology, Samsung Cheil Hospital & Women's Healthcare Center, Sungkyunkwan University School of Medicine)
  • 발행 : 2005.03.30

초록

Objective: To evaluate the effectiveness of aromatase inhibitor (AI) for ovulation induction in polycystic ovary syndrome (PCOS) patients with thin endometrium, hyper-responsiveness after clomiphene citrate (CC) treatment. Material and Methods: A prospective study was performed in 43 PCOS patients (50 cycles) with ovulatory dysfunction between March 2004 and September 2004. AI group (total 36 cycles) included the patients 1) with thin endometrium below 6 mm on hCG day after CC (n=17), 2) with more than 5 ovulatory follicles after 50mg of CC (n=4), 3) who do not want multiple pregnancy (n=14). Patients were treated with Letrozole 2.5mg for days 3 to 7 of the menstrual cycle. CC group (total 14 cycles) were treated with CC 50~100 mg. Results: In PCOS patients, ovulation was occurred 97.2% after AI use. Between AI group and CC group, there was no significant difference in the mean age, duration of infertility, interval of menstruation, basal FSH, prior treatment cycles, and the day of hCG administration. But, the number of mature follicles (${\geq}15mm$) was lower in the AI group ($1.08{\pm}0.45$ vs. $1.64{\pm}0.75$) (p=0.018), and the thickness of endometrium (mm) was significantly thicker in the AI group ($10.35{\pm}1.74$ vs. $9.23{\pm}1.61$) (p=0.044), and E2 (pg/ml) concentration on hCG day was lower in the AI group ($116.9{\pm}75.8$ vs. $479.5{\pm}300.8$) (p=0.001). Among the AI group, patients with prior thin endometrium (below 6 mm) during CC treatment showed $10.6{\pm}1.6mm$ in the endometrial thickness and $106.6{\pm}66.8pg/ml$ in $E_2$ concentration. Patients with more than 5 ovulatory follicles after CC showed decreased follicle number ($1.25{\pm}0.5$) compared to prior CC cycle. Conclusions: In PCOS patients, AI group showed significantly thicker endometrium, lesser number of mature follicles, and lower E2 concentration on hCG day than CC group. AI might be useful alternative treatment for ovulation induction in PCOS patients with thin endometrium and hyper-responsiveness after CC treatment.

키워드

참고문헌

  1. Shoham Z, Weissman A. Polycystic ovarian disease: obesig and insulin resistance. In: Kempers RD, Cohen J, Haney AF, Youger JB, eds. Fertility and reproductive medicine. Amsterdam, New York, Oxford, Shannon, Singapore, Tokyo:Elsevier, 1998: 263-72
  2. Casper RF. Letrozole: ovulation or superovulation? Fertil Steril 2003 Dec; 80(6): 1335-7 https://doi.org/10.1016/j.fertnstert.2003.05.004
  3. Adashi EY, McClarnrock HD. ACOG technical bulletin. Washington, DC: American College of Obstetricians and Gynecologists, 1994, Number 197
  4. Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 2001; 75(2): 305-9. https://doi.org/10.1016/S0015-0282(00)01705-2
  5. Dickey RP, Holtkamp DE. Development, phanna-cology and clinical experience with clomiphene citrate. Hum Reprod Update 1996; 2: 483-506 https://doi.org/10.1093/humupd/2.6.483
  6. Fisher SA, Reid RL, Van Vugt DA, Casper R. A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women. Fertil Steril 2002; 78(2): 280-5. https://doi.org/10.1016/S0015-0282(02)03241-7
  7. Young JR Jaffe RB. Strength-duration characteristics of estrogen effects on gonadotropin response to gonadotropin-releasing hormone in women. II. Effects of varying concentrations of estradiol. J Clin Endocrinol Metab 1976; 42: 432 https://doi.org/10.1210/jcem-42-3-432
  8. Shetty G, Krishnamurthy H, Krishnamurthy HN, Bhatnagar AS, Moudgal RN. Effect of estrogen deprivation on the reproductive physiology of male and female primates. J Steroid Biochem Molec Bioi 1997; 61(3-6): 157-66 https://doi.org/10.1016/S0960-0760(97)80008-8
  9. Mitwally MF, Casper RF. Aromatase inhibition improves ovarian response to follicle-stimulation hormone in poor responders. Fertil Steril 2002; 77: 776 -80 https://doi.org/10.1016/S0015-0282(01)03280-0
  10. Cortinez A, Carvalho LD, Vantman D, Gabler F, Iniguez G, Vega M. Hormonal profile and endometrial morphology in letrozole-controlled ovarian hyperstimulation in ovulatory infertile patients. Fertil Steril 2005; 83(1):110-15 https://doi.org/10.1016/j.fertnstert.2004.05.099
  11. Healey S, Tan SL, Tulandi T, Biljan MM. Effects of letrozole on superovulation with gonadotropins in women undergoing intrauterine insemination. Fertil Steril 2003; 80: 1325-9. https://doi.org/10.1016/j.fertnstert.2003.03.001
  12. Mitwally MF, Biljan MM, Casper RF. Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. Am J Ob Gy 2005; 192: 381-6 https://doi.org/10.1016/j.ajog.2004.08.013
  13. Biljan MM, Tan SL, Tulandi T. Prospective randomized trial comparing the effects of 2.5 and 5.0 mg of letrozole (LE) on follicular development, endometrial thickness and pregnancy rates in patients undergoing super-ovulation (abstract 0-143). Fertil Steril 2002; 78: S55
  14. Mitwally MF, Casper RF. Aromatase inhibition reduces gonadotropin dose required for controlled ovarian stimulation in women with unexplained infertility. Hum Reprod 2003;.18(8): 1588-97 https://doi.org/10.1093/humrep/deg311
  15. Healey S, Tan SL, Bi!jan MM, Tulandi T. Letrozole and gonadotropins: What is the ideal patient protocol? Pertil Steril 2003; 80(6): 1339 https://doi.org/10.1016/j.fertnstert.2003.08.001
  16. Bulun SE. Ovulation induction in women with infertility: a new indication for aromatase inhibitors. FertH Steril 2003; 80(6): 1338 https://doi.org/10.1016/j.fertnstert.2003.06.001
  17. Fang Z, Yang S, Gurantes B, Tamura M, Simpson E, Evans D, Bulun SE. Genetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tissue J Clin Endo Metab 2002; 87(7): 3460 -6 https://doi.org/10.1210/jc.87.7.3460